|
⚲
|
| Keyboard |
| Kroin David
✚
|
|
|---|---|
| CIK # | 0001397513 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Genesis Biopharma Inc | 102.3 | ||
| Zymeworks Inc | 92.9 | ||
| Acadia Pharmaceuticals Inc | 87.5 | ||
| United Therapeutics Corp | 75.0 | ||
| Manhattan Pharmaceuticals Inc | 64.7 | ||
| Biohaven Ltd | 61.5 | ||
| Akebia Therapeutics Inc | 47.7 | ||
| Macrogenics Inc | 41.9 | ||
| Cytokinetics Inc | 35.8 | ||
| Geron Corp | 33.6 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001397513] | |
| 3 | [0001397513] | |
| 4 | [0001397513] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dynavax Technologies Corp DVAX
Common Stock, par value $0.001 per share
|
2026-02-10 | Tender | 15,726,349 | ||
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 93,925 | $21.17 | 1,988,392 |
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 378,444 | $21.17 | 8,011,659 |
|
Nektar Therapeutics NKTR
Common Stock
|
2024-05-10 | Sell | 56,000 | $1.78 | 99,680 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2017-06-21 | Sell | 10,000 | $17.44 | 174,400 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2017-06-20 | Sell | 20,000 | $17.35 | 347,000 |
|
Adamas Pharmaceuticals Inc ADMS
Common Stock
|
2017-06-19 | Sell | 350,000 | $17.05 | 5,967,500 |
|
Connecture Inc CNXR
Common Stock
|
2015-06-30 | Gift | 10,000 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2015-06-10 | Other | 1,375,733 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2015-06-10 | Other | 47,235 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2015-06-10 | Other | 36,493 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2015-06-10 | Other | 28,696 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2015-06-10 | Other | 39,703 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2014-12-17 | Sell | 395,886 | $8.00 | 3,167,088 |
|
Connecture Inc CNXR
Series B Preferred Stock · derivative
|
2014-12-17 | Conversion | 17,696,553 | $0.00 | |
|
Connecture Inc CNXR
Common Stock
|
2014-12-17 | Conversion | 5,898,851 |